Dear Partners in Health,
As we begin the 2026 calendar year, the North Carolina Immunization Program (NCIP) extends its sincere appreciation for your continued partnership and commitment to improving immunization outcomes across North Carolina.
This communication provides important program and vaccine updates. Please read this message in its entirety to stay informed.
Updated Coverage Criteria
NCIP has updated its Coverage Criteria with a newly designed format to make it easier to view eligibility for state-supplied vaccines.
Providers should refer to the updated Coverage Criteria for all state-supplied vaccine use.
North Carolina Measles Cases/Webinar
North Carolina is seeing an increase in Measles cases. Providers are encouraged to review the NCDHHS Jan 6 press release for more information.
Join experts from the NC Communicable Disease Branch and the NC State Laboratory of Public Health today for a webinar providing timely updates on the measles outbreak in South Carolina and its effects on North Carolina.
Date: Friday, January 9, 2025
Time: 12:00–1:00 PM
Format: Online Event
Click Here to Register for Webinar
Registration is required to receive the webinar link.
As a reminder to providers: early identification, reporting, and vaccination are crucial to limiting the spread of measles.
Resources for Providers
- NCDHHS Measles Webpage: Measles (Rubeola) | Division of Public Health
- Resources for Health Care Providers
- Webinar Slides: Measles Update for Clinical Providers (pdf)
- Provider Memo: Measles Reporting, Testing and Vaccination (pdf)
- Identifying Cases and Infection Control Laboratory Testing
NCIP Transition to One Fax Line
- Our NCIP Central Office now has one fax number: 800-544-3058
- Regional Consultants with individual numbers will continue to be available
FluMist® Advance Bulk Order Update
FluMist® will no longer be available for ordering after January 12, 2026. Current shipments will expire on January 19, 2026.
If you need additional flu vaccine, please refer to the Flu Vaccine Product Availability and Ordering memo for alternative options.
Reminder: Maternal ABRYSVO® Administration Ends This Month
The last day to administer ABRYSVO® for pregnant persons is January 31, 2026 for the 2025-2026 RSV season. In accordance with the Advisory Committee on Immunization Practices (ACIP) recommendations.
As the RSV season ends, note the following key points:
- Administration of ABRYSVO® for pregnant persons will not be permitted after January 31st.
- Any remaining unexpired VFC and 317 VFA doses of ABRYSVO® should be labeled as "DO NOT USE" and stored under the appropriate storage conditions.
- Administering of ABRYSVO® to pregnant persons can resume on Sept. 1, 2026, for the next RSV season.
Privately purchased ABRYSVO® may be administered to individuals aged 60 and older, regardless of the time of year (although late summer/early fall is preferred).
Nirsevimab (Beyfortus®) and clesrovimab (ENFLONSIA™) (for infants and toddlers) can continue to be administered through March 31, 2026.
Upcoming Lunch and Learn-Respiratory Vaccine Dashboards
Join us for an overview of the newly released Respiratory Vaccine Dashboards, which provide key insights into doses administered and estimated coverage for COVID-19, flu, and RSV across North Carolina.
Date: January 21, 2026
Time: 12:00 – 12:45pm
Topic: Respiratory Vaccine Dashboards
Click Here to Register
Meeting ID: 161 461 6668
Passcode: 317291
Mark your calendars for additional 2026 Lunch and Learn dates:
- April 15, 2026
- July 15, 2026
- October 21, 2026
We thank you again for your dedication and contributions to improving immunization efforts across North Carolina.
How to contact us:
For assistance, please contact the NCIP Help Desk by phone at 1.877.USE.NCIR (1-877-873-6247) or by email.
In Health,
NC Department of Health and Human Services